These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

214 related articles for article (PubMed ID: 10604722)

  • 1. Inhibition of haematogenous metastasis of colon cancer in mice by a selective COX-2 inhibitor, JTE-522.
    Tomozawa S; Nagawa H; Tsuno N; Hatano K; Osada T; Kitayama J; Sunami E; Nita ME; Ishihara S; Yano H; Tsuruo T; Shibata Y; Muto T
    Br J Cancer; 1999 Dec; 81(8):1274-9. PubMed ID: 10604722
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The potential for a selective cyclooxygenase-2 inhibitor in the prevention of liver metastasis in human colorectal cancer.
    Yamauchi T; Watanabe M; Hasegawa H; Nishibori H; Ishii Y; Tatematsu H; Yamamoto K; Kubota T; Kitajima M
    Anticancer Res; 2003; 23(1A):245-9. PubMed ID: 12680220
    [TBL] [Abstract][Full Text] [Related]  

  • 3. JTE-522, a selective COX-2 inhibitor, inhibits growth of pulmonary metastases of colorectal cancer in rats.
    Kobayashi H; Uetake H; Higuchi T; Enomoto M; Sugihara K
    BMC Cancer; 2005 Mar; 5():26. PubMed ID: 15743541
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Inhibitory effect of a selective cyclooxygenase-2 inhibitor on liver metastasis of colon cancer.
    Nagatsuka I; Yamada N; Shimizu S; Ohira M; Nishino H; Seki S; Hirakawa K
    Int J Cancer; 2002 Aug; 100(5):515-9. PubMed ID: 12124799
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Induction of apoptosis by JTE-522, a specific cyclooxygenase-2 inhibitor, in human gastric cancer cell lines.
    Uefuji K; Ichikura T; Shinomiya N; Mochizuki H
    Anticancer Res; 2000; 20(6B):4279-84. PubMed ID: 11205258
    [TBL] [Abstract][Full Text] [Related]  

  • 6. NS-398 inhibits tumor growth and liver metastasis of colon cancer through induction of apoptosis and suppression of the plasminogen activation system in a mouse model.
    Nishikawa M; Stapleton PP; Freeman TA; Gaughan JP; Matsuda T; Daly JM
    J Am Coll Surg; 2004 Sep; 199(3):428-35. PubMed ID: 15325613
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Selective cyclooxygenase (COX)-1 or COX-2 inhibitors control metastatic disease in a murine model of breast cancer.
    Kundu N; Fulton AM
    Cancer Res; 2002 Apr; 62(8):2343-6. PubMed ID: 11956094
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Combined treatment with selective cyclooxygenase-2 inhibitor and fluorinated pyrimidines for liver metastasis of colon cancer.
    Matsunaga N; Yamada N; Ohira M; Tachimori A; Nishiguchi Y; Nishino H; Seki S; Hirakawa K
    Oncol Rep; 2004 Jan; 11(1):167-71. PubMed ID: 14654921
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Direct evidence for a role of cyclooxygenase 2-derived prostaglandin E2 in human head and neck xenograft tumors.
    Zweifel BS; Davis TW; Ornberg RL; Masferrer JL
    Cancer Res; 2002 Nov; 62(22):6706-11. PubMed ID: 12438270
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Chemoprevention of colon cancer by specific cyclooxygenase-2 inhibitor, celecoxib, administered during different stages of carcinogenesis.
    Reddy BS; Hirose Y; Lubet R; Steele V; Kelloff G; Paulson S; Seibert K; Rao CV
    Cancer Res; 2000 Jan; 60(2):293-7. PubMed ID: 10667579
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Dual inhibition of 5-LOX and COX-2 suppresses colon cancer formation promoted by cigarette smoke.
    Ye YN; Wu WK; Shin VY; Bruce IC; Wong BC; Cho CH
    Carcinogenesis; 2005 Apr; 26(4):827-34. PubMed ID: 15637091
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Chemopreventive properties of a selective inducible nitric oxide synthase inhibitor in colon carcinogenesis, administered alone or in combination with celecoxib, a selective cyclooxygenase-2 inhibitor.
    Rao CV; Indranie C; Simi B; Manning PT; Connor JR; Reddy BS
    Cancer Res; 2002 Jan; 62(1):165-70. PubMed ID: 11782374
    [TBL] [Abstract][Full Text] [Related]  

  • 13. JTE-522, a selective COX-2 inhibitor, interferes with the growth of lung metastases from colorectal cancer in rats due to inhibition of neovascularization: a vascular cast model study.
    Kobayashi H; Gonda T; Uetake H; Higuchi T; Enomoto M; Sugihara K
    Int J Cancer; 2004 Dec; 112(6):920-6. PubMed ID: 15386343
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cyclooxygenase-2-selective nonsteroidal anti-inflammatory drugs inhibit hepatocyte growth factor/scatter factor-induced angiogenesis.
    Sengupta S; Sellers LA; Cindrova T; Skepper J; Gherardi E; Sasisekharan R; Fan TP
    Cancer Res; 2003 Dec; 63(23):8351-9. PubMed ID: 14678996
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cyclooxygenase-2 overexpression correlates with tumour recurrence, especially haematogenous metastasis, of colorectal cancer.
    Tomozawa S; Tsuno NH; Sunami E; Hatano K; Kitayama J; Osada T; Saito S; Tsuruo T; Shibata Y; Nagawa H
    Br J Cancer; 2000 Aug; 83(3):324-8. PubMed ID: 10917546
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Significant growth inhibition of human lung cancer cells both in vitro and in vivo by the combined use of a selective cyclooxygenase 2 inhibitor, JTE-522, and conventional anticancer agents.
    Hida T; Kozaki K; Ito H; Miyaishi O; Tatematsu Y; Suzuki T; Matsuo K; Sugiura T; Ogawa M; Takahashi T; Takahashi T
    Clin Cancer Res; 2002 Jul; 8(7):2443-7. PubMed ID: 12114451
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [COX-2 inhibitor and colon cancer].
    Tsujii M
    Gan To Kagaku Ryoho; 2001 Nov; 28(12):1799-805. PubMed ID: 11729471
    [TBL] [Abstract][Full Text] [Related]  

  • 18. JTE-522, a selective cyclooxygenase-2 inhibitor, inhibits induction but not growth and invasion of 1,2-dimethylhydrazine-induced tubular adenocarcinomas of colon in rats.
    Wei M; Morimura K; Wanibuchi H; Shen J; Salim EI; Moku M; Hakoi K; Fukushima S
    Int J Cancer; 2005 Jan; 113(3):354-8. PubMed ID: 15455344
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cyclooxygenase inhibitors suppress angiogenesis and reduce tumor growth in vivo.
    Sawaoka H; Tsuji S; Tsujii M; Gunawan ES; Sasaki Y; Kawano S; Hori M
    Lab Invest; 1999 Dec; 79(12):1469-77. PubMed ID: 10616198
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cyclooxygenase-2 overexpression reduces apoptotic susceptibility by inhibiting the cytochrome c-dependent apoptotic pathway in human colon cancer cells.
    Sun Y; Tang XM; Half E; Kuo MT; Sinicrope FA
    Cancer Res; 2002 Nov; 62(21):6323-8. PubMed ID: 12414664
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.